Pulsatile Release of Human Gonadotropin Releasing Hormone Using a Photoactivated Depot Containing an Unusual Light...

Area of Science:

• Biomaterials Science
• Endocrinology
• Drug Delivery Systems

Background:

• Pulsatile hormone release is physiologically crucial, differing significantly from continuous delivery.
• Gonadotropin-releasing hormone (GnRH) plays a key role in various physiological processes and is being investigated for conditions such as cognitive impairment in Down syndrome.
• Existing methods for controlled hormone release may not effectively mimic natural pulsatile patterns.

Purpose of the Study:

• To develop and characterize a photoactivated depot (PAD) system for the pulsatile release of human gonadotropin-releasing hormone (GnRH).
• To utilize green light as an external trigger for controlled GnRH delivery.
• To address the synthetic challenge of linking GnRH to a photocleavable moiety via an unusual chemical linkage.

Main Methods:

• Synthesis of a GnRH-loaded photoactivated depot (PAD) material using a green light-activated thiocoumarin photocleavable group.
• Characterization of the PAD material's stability against chemical hydrolysis.
• Demonstration of pulsatile GnRH release upon exposure to 500 nm green light.
• Utilized proteolysis and de novo peptide sequencing to identify the linkage site on GnRH.

Main Results:

• Successfully synthesized an insoluble GnRH PAD material that releases soluble GnRH upon green light activation.
• Identified an unusual linkage of GnRH via its arginine guanidino group to the photocleavable moiety, overcoming a major synthetic hurdle.
• Demonstrated the material's high stability towards chemical hydrolysis.
• Confirmed pulsatile release of GnRH in response to 500 nm light pulses.

Conclusions:

• The photoactivated depot (PAD) approach is effective for achieving light-triggered pulsatile release of gonadotropin-releasing hormone (GnRH).
• The developed GnRH PAD system offers a novel, stable, and controllable method for hormone delivery.
• This technology holds potential for therapeutic applications requiring precise control over GnRH release, such as in treating cognitive impairment associated with Down syndrome.